Invivoscribe® Receives FDA Approval for the LeukoStrat® CDx FLT3 Mutation Assay Companion Diagnostic Test for the Selection of Patients for Rydapt® and is the First Companion Diagnostic for AML

SAN DIEGO, April 28, 2017 (GLOBE NEWSWIRE) — Invivoscribe® Technologies Inc., a global company with more than 20 years of experience providing clonality and biomarker test solutions for the fields of oncology, personalized molecular diagnostics® and personalized molecular medicine®, today announces the premarket approval of LeukoStrat® CDx FLT3 Mutation Assay.  Due to current labeling for the FDA approved test, FLT3 mutation testing with LeukoStrat® CDx FLT3 Mutation Assay is exclusively performed by The Laboratory for Personalized Molecular Medicine, a subsidiary of Invivoscribe Technologies, Inc., which has gained FDA approval for its FLT3 test as a companion diagnostic for the Novartis drug Rydapt® in newly diagnosed FLT3+ AML.

Under terms of a previously announced agreement with Thermo Fisher, Invivoscribe will also seek FDA approval of the LeukoStrat® CDx FLT3 Mutation Assay that will allow the sale of kits to other laboratories. The Invivoscribe LeukoStrat® CDx FLT3 Mutation Assay is a signal ratio assay that identifies both internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, and identifies even large ITD mutations, which are missed using many current NGS-based assays.

FLT3 somatic variants are among the most common driver mutations with the strongest effects on the overall survival in acute myeloid leukemia1 (AML), the most deadly form of leukemia, which is diagnosed in about 20,000 new patients each year in the U.S. and has only a 26.6 percent five-year survival rate2. Invivoscribe, working under a companion diagnostic agreement with Novartis, developed this companion diagnostic for FLT3 successfully achieving FDA regulatory approval. The Invivoscribe LeukoStrat® CDx FLT3 Mutation Assay is the first companion diagnostic for AML.

“This test approval will be of substantial benefit to patients afflicted with AML and is a critical tool for healthcare providers to identify the most appropriate treatment for newly diagnosed FLT3-mutated AML patients, furthering the promise of personalized molecular diagnostics and precision medicine,” said Dr. Jeffrey Miller, CSO & CEO of Invivoscribe. “And, as has been previously noted by others3, there is a need for an internationally standardized FLT3 mutation assay and this companion diagnostic is a step toward fulfilling that need.”

About Invivoscribe
Invivoscribe® Technologies Inc. is a privately held biotechnology company dedicated to improving the quality of healthcare worldwide by providing high quality, reliable, cutting-edge reagents, tests, and bioinformatics tools to advance the fields of personalized molecular diagnostics® and personalized molecular medicine®. Invivoscribe provides ISO 13485 certified, PCR- and NGS-based reagents manufactured in a facility registered with FDA; RUO test kits; CE-marked IVDs, including IdentiClone® and LymphoTrack® Dx Assays with both LymphoTrack® and LymphoTrack® Dx Software; for clonality, MRD, and somatic hypermutation testing. Invivoscribe also offers comprehensive MyAML®, MyHeme®, MyMRD®, and custom gene panels. Used in combination with Invivoscribe’s proprietary MyInformatics® Software these assays identify and can track primary driver mutations as well as the subclonal architecture and emergence of new driver mutations in patients with hematologic disease. Invivoscribe’s clinical laboratories in the USA, Europe, and Japan provide international access to harmonized CLIA, CAP, and ISO 15189 accredited clinical testing and contract research organization (CRO) services.  Invivoscribe’s clinical testing services, tests and reagents are currently being used in more than 650 clinical and research laboratories in 65 countries. Invivoscribe has long embraced the value of quality systems and develops all products, including bioinformatics software, compliant with ISO 13485 design control, making them eligible to be brought through regulatory process to authorities worldwide.  Additional information can be found at www.invivoscribe.com and www.flt3cdx.com.

References:
1. Papaemmanuil E, Gerstung M, Bullinger L, et al.  N Engl J Med 2016;374(23):2209-2221
2. https://seer.cancer.gov/statfacts/html/amyl.html
3. Levis, M. Hematology Am Soc Hematol Educ Program 2013;2013:220-6

CONTACT:
Kevin Dobyns 858-224-6600

MSAB Announces XAMN Spotlight 2.0

Global Industry Leader updates technology, allowing investigators to get answers faster, easier and with greater precision

ARLINGTON, Va., April 27, 2017 (GLOBE NEWSWIRE) — MSAB, a global leader in forensic technology for mobile device examination, today announced XAMN Spotlight 2.0, a product designed with the needs of the modern investigator in mind. XAMN Spotlight 2.0 is built for finding and analyzing data faster, more efficiently and expediently. MSAB introduces powerful new features to the product, such as search filters. Enhanced views help investigators improve speed and accuracy, a new Source Mode was integrated to verify hex data, the ability to pivot investigations around individual artifacts, and multi-monitor support, make up some of the many upgrades.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/96bfbb14-28b8-447e-841b-9d9d98864061

As the amount of data in smartphones steadily increases, investigators are tasked with sifting through thousands of messages and gigabytes of information to find the relevant facts. This is only getting harder to achieve.

“We know that investigators are an integral part of law enforcement, so continuing to increase their efficiency is critical for future success,” said Joel Bollö, CEO of MSAB. “Spotlight 2.0 is focused on supporting those investigators that know what they are looking for, as well as digital forensic investigators who are interested in the output of a mobile device examination. It combines ease of use, with powerful searching capabilities, and can be efficiently utilized.”

Spotlight is the flagship tool in the new suite of XAMN analysis products from MSAB. Spotlight has evolved to become much more powerful. Spotlight 2.0 includes four different views, each of which displays different aspects of the case.

XAMN Spotlight 2.0. Now more powerful than ever.

  • Review of multiple XRY extractions in one application
  • Source Mode to allow review of original hex data
  • Powerful filter search capabilities
  • Power tagging
  • Quick views
  • Extensive reporting functionality
  • Intuitive user interface
  • Multi-Monitor support
  1. The XAMN Spotlight 2.0 lets investigators and specialists quickly identify critical information, whether through a big picture or with precise details. Its power search capabilities allow a user to pull and analyze from huge data sets of mobile evidence.
  2. XAMN Spotlight is simple to use and minimizes the requirement for infrastructure and training. Every investigator can directly take advantage of the power of XAMN Spotlight to solve crimes faster, resulting in financial savings and improved efficiency.
  3. XAMN is a suite of analysis tools designed primarily to help investigators and forensic specialists work more efficiently.
  4. XAMN Spotlight 2.0 is very flexible, allowing you to scale it according to your organizational needs and requirements.

For more information about MSAB and its products go to www.msab.com

About MSAB:

MSAB is a world leader in mobile forensics technology with the aim of extracting and analyzing data from confiscated mobile devices, mainly mobile phones. The company has its own sales offices and sales representatives in Europe, North America, South America, China, Australia and Russia, and together with a number of distributors covers most of the world. The company’s proprietary products have become a de facto standard in the field and are used for securing evidence in over 100 countries. The products are complemented by a wide range of training courses, with the opportunity to become certified in a forensically sound method of extracting data from mobile devices. Customers are primarily authorities involved in performing criminal investigations, and include police, military and customs. MSAB is listed on NASDAQ Stockholm under the ticker symbol: MSAB B.

Organization Number: 556244-3050 | VAT No: SE556244305001 Hornsbruksgatan 28, SE-117 34 Stockholm, Sweden Phone +46 8739 0270 | Fax +46 8730 0170 www.msab.com | [email protected]com

 

Mike Dickinson
46 85 99 22 520
[email protected]

Taconic Biosciences Expands Microbiome Product and Service Platform

HUDSON, N.Y., April 26, 2017 (GLOBE NEWSWIRE) — Taconic Biosciences, a global leader in genetically engineered mouse models and associated services and the only commercial provider of germ-free mice, announced that effective April 26, 2017 they will expand their microbiome product and services platform to include custom Fecal Microbiota Transplantation (FMT) services. To support these new FMT services, Taconic will also offer custom germ-free derivations using either client mouse models, Taconic’s commercial offerings, or mice sourced from third parties.

This new FMT service offering capitalizes on Taconic’s decades of microbiome experience, existing portfolio of germ-free offerings including Germ-Free C57BL/6NTac and Swiss Webster mice, and ability to derive germ-free animals from Taconic’s large catalog of mutant mice or client-provided models.

Dr. Alexander Maue, Taconic Biosciences’ portfolio director for microbiome products and services, commented, “The germ-free mouse is the ideal substrate to evaluate the properties of complex or defined gut microbiota following FMT. Axenic mice transplanted with donor microbiota can be used to assess the effects of gut bacteria on a wide range of biological systems, including but not limited to, immunity, neurodegenerative diseases, obesity, and diabetes.”

“Our custom germ-free derivation services enable Taconic to generate initial cohorts of up to 40 germ-free animals, allowing researchers to generate rapid study cohorts.”

Prior to the start of any custom FMT project or germ-free derivation service, Taconic consults with the client to understand their research goals and develop a strategy for project execution. A dedicated Project Manager will keep clients updated throughout the project. Following FMT, Taconic offers a range of husbandry options to accommodate studies of all sizes and durations including options for isolators and state of the art individually ventilated cages (IVCs).

In addition to providing microbiome products and services, Taconic also is a fully-licensed provider of rodent model generation services and has twenty years of model design experience. Complimenting this expertise is Taconic’s unique capability of providing a seamless transition from model design to breeding and colony management, thus offering customers a complete solution. These scientific services include acquiring or generating, importing, licensing, breeding, testing, preparing, and distributing genetically engineered models to any location worldwide.

To learn more about Taconic’s microbiome products and services, please contact Taconic Biosciences at 1-888-TACONIC (888-822-6642) in the US, +45 70 23 04 05 in Europe or at [email protected].

About Taconic Biosciences, Inc.

Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic helps biotechnology companies and institutions acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide.  Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.

Media Contact:

Kelly Owen Grover

Director of Marketing Communications

(518) 697-3824

[email protected]

Nasdaq Reports Record Quarterly Earnings; Announces 19% Increase in Quarterly Dividend

  • Net revenues1 were $583 million in the first quarter of 2017, an increase of 9% compared to the first quarter of 2016. Subscription and recurring revenues2 in the first quarter of 2017 represented 75% of total net revenues.
  • First quarter 2017 GAAP diluted EPS was $0.99, while non-GAAP diluted EPS was $1.103. Compared to the first quarter of 2016, GAAP diluted EPS increased $0.21, or 27%, while non-GAAP diluted EPS increased $0.19, or 21%.
  • Revenues in non-trading segments4 in the first quarter of 2017 increased 10% compared to the first quarter of 2016, including organic growth of 5%.  Market Technology organic revenue growth was 18% from the prior year period.
  • As of March 31, 2017, the company achieved $50 million in annualized run-rate cost synergies out of a targeted $60 million expected within eighteen months of the respective 2016 acquisition closing dates.
  • Nasdaq announced a 19% increase in the quarterly dividend to $0.38, and in the first quarter of 2017 repurchased $156 million of its common stock.  Dividends and buybacks totaled $209 million during the first quarter of 2017.

NEW YORK, April 26, 2017 (GLOBE NEWSWIRE) — Nasdaq, Inc. (Nasdaq:NDAQ) today reported financial results for the first quarter of 2017.  First quarter net revenues were $583 million, up $49 million or 9% from $534 million in the prior year period.  The first quarter increase in net revenues included a $50 million positive impact from acquisitions and $15 million, or 5%, organic growth in non-trading segments, partially offset by a $12 million organic decline in Market Services net revenues driven by lower industry trading volumes, as well as an overall $4 million impact from unfavorable changes in foreign exchange rates.

“I’m pleased Nasdaq was able to set new highs in terms of operating income and EPS, and deliver continued strong organic revenue growth across the non-transactional businesses, despite a challenging trading volume environment,” said Adena T. Friedman, President and CEO, Nasdaq. “Importantly, we are seeing growth in areas where we’ve invested materially to innovate for the benefit of our clients, bringing them new or enhanced capabilities and efficiencies, in particular in the Market Technology, Information Services and Corporate Solutions businesses.”

Ms. Friedman continued, “We have made significant early progress towards our 2017 execution priorities.  We have improved our competitive position, as evidenced by higher market share in several key trading markets, progressed on our acquisition integrations, and continued our efforts to commercialize key disruptive technologies, as illustrated by early sales success of the Nasdaq Financial Framework, our next generation Market Technology offering.”

GAAP operating expenses were $335 million in the first quarter of 2017, up $20 million from $315 million in the first quarter of 2016. The increase primarily reflects incremental operating expenses from the acquisitions closed in 2016.

Non-GAAP operating expenses were $306 million in the first quarter of 2017, up $26 million from $280 million in the first quarter of 2016. This increase reflects $22 million of incremental operating expenses from the acquisitions closed in 2016 as well as $7 million due to organic growth, partially offset by a $3 million favorable impact from foreign exchange rate changes.

“We are making significant progress executing against our acquisition integration plans, and we remain on pace to hit our synergy target of $60 million by the end of 2017,” said Michael Ptasznik, Executive Vice President and Chief Financial Officer, Nasdaq.

Mr. Ptasznik continued, “We are continuing Nasdaq’s strong track record on capital returns to shareholders with the announced 19% increase in our quarterly dividend and material first quarter share repurchases, the latter expected to largely offset the dilutive impact of equity-based compensation and other commitments in 2017.”

1 Represents revenues less transaction-based expenses.

2 Represents revenues from our Corporate Services, Information Services and Market Technology segments, as well as our Trade Management Services business.

3 Refer to our reconciliations of U.S. GAAP to non-GAAP net income (loss), diluted earnings (loss) per share, operating income and operating expenses, and total variance impact analysis included in the attached schedules.

4 Represents revenues from our Corporate Services, Information Services and Market Technology segments.

On a GAAP basis, net income attributable to Nasdaq for the first quarter of 2017 was $169 million, or $0.99 per diluted share, compared with net income of $132 million, or $0.78 per diluted share, in the first quarter of 2016.

On a non-GAAP basis, net income attributable to Nasdaq for the first quarter of 2017 was $187 million, or $1.10 per diluted share, compared with $153 million, or $0.91 per diluted share, in the first quarter of 2016.

As discussed on our prior quarterly call, both GAAP and non-GAAP net income and EPS comparisons to the prior year period benefited from the 2017 adoption of ASU 2016-091, which in the first quarter of 2017 reduced the effective tax rate on our income statement, adding $0.13 to diluted EPS for the first quarter of 2017.  Cash tax payments were not affected by the change.

During the first quarter of 2017, the company repurchased 2.2 million shares of common stock for a total cost of $156 million.  As of March 31, 2017, there was $273 million remaining under the board authorized share repurchase program.

At March 31, 2017, the company had cash and cash equivalents of $386 million and total debt of $3,621 million, resulting in net debt of $3,235 million. This compares to net debt of $3,200 million at December 31, 2016.

DEBT RESTRUCTURING – Nasdaq announced it will redeem all of its outstanding 5.25% senior notes maturing January 2018 on May 26, 2017.  The notes will be redeemed using a combination of cash on hand and proceeds from the sale of commercial paper issued through Nasdaq’s newly established commercial paper program.  Additionally, the company entered into an agreement for a $1 billion five-year revolving credit facility, which replaces its existing $750 million revolving credit facility.  Nasdaq intends to use funds available under the revolving credit facility for general corporate purposes and to provide liquidity support for the repayment of commercial paper issued through its commercial paper program.

2017 EXPENSE GUIDANCE2The company is lowering its 2017 non-GAAP operating expense guidance to $1,260 to $1,300 million, versus prior 2017 guidance of $1,260 to $1,310 million.

1 In the first quarter of 2017, we adopted new accounting guidance which requires us to recognize the tax effect related to the vesting of share-based awards in income tax expense in the statements of income rather than in equity.

2 U.S. GAAP operating expense guidance is not provided due to the inherent difficulty in quantifying certain amounts due to a variety of factors including the unpredictability in the movement in foreign currency rates, as well as future charges or reversals outside of the normal course of business.

BUSINESS HIGHLIGHTS

Market Services (37% of total net revenues) – Net revenues were $218 million in the first quarter of 2017, up $17 million when compared to the first quarter of 2016.

Equity Derivatives (12% of total net revenues) – Net equity derivative trading and clearing revenues were $68 million in the first quarter of 2017, up $20 million compared to the first quarter of 2016. The increase is primarily due to the inclusion of revenues from the acquisition of ISE in June 2016.

Cash Equities (10% of total net revenues) – Net cash equity trading revenues were $61 million in the first quarter of 2017, down $9 million from the first quarter of 2016. This decrease primarily reflects lower industry trading volumes, partially offset by the inclusion of net revenues associated with the acquisition of Nasdaq CXC in February 2016.

Fixed Income and Commodities Trading and Clearing (3% of total net revenues) – Net fixed income and commodities trading and clearing (FICC) revenues were $19 million in the first quarter of 2017, down $1 million from the first quarter of 2016.

Trade Management Services (12% of total net revenues) – Trade management services revenues were
$70 million in the first quarter of 2017, up $7 million compared to the first quarter of 2016, due to the inclusion of revenue from the acquisition of ISE and an increase in customer demand for network connectivity.

Corporate Services (27% of total net revenues) – Revenues were $160 million in the first quarter of 2017, up $17 million compared to the first quarter of 2016.

Corporate Solutions (16% of total net revenues) – Corporate solutions revenues were $95 million in the first quarter of 2017, up $18 million from the first quarter of 2016. The increase was due to the inclusion of $16 million of revenues from the Marketwired and Boardvantage acquisitions and $2 million of organic revenue growth, primarily in public and investor relations.

Listing Services (11% of total net revenues) – Listing services revenues were $65 million in the first quarter of 2017, down $1 million from the first quarter of 2016.  The revenue decrease was primarily due to a $1 million negative impact from foreign exchange rate changes.

Information Services (24% of total net revenues) – Revenues were $138 million in the first quarter of 2017, up $5 million from the first quarter of 2016.

Data Products (19% of total net revenues) – Data products revenues were $108 million in the first quarter of 2017, up $3 million compared to the first quarter of 2016 primarily due to growth in proprietary data products revenues and the inclusion of revenues from the acquisition of ISE.

Index Licensing and Services (5% of total net revenues) – Index licensing and services revenues were $30 million in the first quarter of 2017, up $2 million from the first quarter of 2016.  The revenue increase is due to the inclusion of revenues from the ISE acquisition and higher assets under management in exchange traded products linked to Nasdaq indexes, partially offset by lower revenue from derivative products licensing Nasdaq indexes due to lower trading volumes.

Market Technology (12% of total net revenues) – Revenues were $67 million in the first quarter of 2017, up $10 million from the first quarter of 2016.  The increase primarily reflects organic revenue growth during the period from software licensing and support, surveillance, and BWise advisory.  New order intake totaled $47 million in the first quarter of 2017, up $25 million from the first quarter of 2016, while total order value was $777 million at March 31, 2017, down 1% from March 31, 2016.

CORPORATE HIGHLIGHTS

  • Market Services achieves market share increases in U.S. equities, U.S. options, and Nordic equities in the first quarter of 2017.  Nasdaq achieved sequential market share gains in the first quarter of 2017 compared to the fourth quarter of 2016 in its largest trading businesses, including U.S. options, U.S. equities, and Nordic equities.  Nasdaq’s U.S. options market share increased to 42.5% in the first quarter of 2017 versus 39.2% in the fourth quarter of 20161.  U.S. equities market share improved to 17.6% in the first quarter of 2017 versus 17.2% in the fourth quarter of 20162, while Nordic equities market share increased to 66.8% in the first quarter of 2017 versus 65.1% in the fourth quarter of 2016.
  • Market Technology order intake totaled $47 million in the first quarter of 2017.  Order intake of $47 million in the first quarter of 2017 included extending and expanding relationships across multiple clients.  Nasdaq announced that Hong Kong Exchange and Clearing Limited (HKEX) will upgrade infrastructure of its main derivatives market across trading, clearing, and real-time risk management.  Another notable contract win came with NEX Group, which is incorporating SMARTS Market Surveillance into its leading foreign exchange platform.
  • The Nasdaq Stock Market led U.S. exchanges for IPOs. In the U.S. market, The Nasdaq Stock Market welcomed 42 new listings during the first quarter of 2017, 17 of which were IPOs including Presidio, Hamilton Lane, and Laureate Education.  During the first quarter, The Nasdaq Stock Market won 52% of IPO listings, and 67% over the twelve months ending March 31, 2017.  The Nasdaq Stock Market also announced 7 new ETP listings in the first quarter of 2017, bringing total ETP listings on The Nasdaq Stock Market to 332 at March 31, 2017, representing a 38% increase versus the first quarter of 2016.
  • Nasdaq saw strong growth and record ETP assets under management tracking Nasdaq indexes. Overall assets under management (AUM) in ETPs benchmarked to Nasdaq’s proprietary index families increased 31% to a record $138 billion as of March 31, 2017 compared to March 31, 2016, including $59 billion, or 42%, tracking smart beta indexes.   Also as of March 31, 2017, the number of ETPs tracking Nasdaq-licensed indexes rose to 306, an increase of 35%, compared to 226 at March 31, 2016.
  • Nasdaq Private Market completes first auction based transaction in partnership interests and expands into alternative investment fund liquidity.  Nasdaq Private Market (NPM) announced the launch of NPM Alternatives, a new business line designed to address the challenge of liquidity in alternative investment funds.  NPM Alternatives will bring together participants including fund managers, financial advisors, investors and secondary liquidity providers to facilitate regular, auction-based liquidity events for alternative investment funds.  NPM will initially support secondary liquidity for private equity feeder funds as well as funds registered under the Investment Company Act of 1940 and plans to accommodate a variety of fund vehicles over time.
  • NFX growth continues Nasdaq’s commodities expansion. NFX, a U.S.-based derivatives market for key energy benchmarks, continues to expand.  In April 2017, open interest in NFX products reached a daily peak of 2.3 million contracts across key product segments including natural gas and power options and futures, up from a daily peak of 800 thousand contracts in April 2016.  During the first quarter of 2017, average daily volume (ADV) was 213,000 contracts, an increase of 184% from 75,000 contracts per day in the first quarter of 2016.  Since its July 2015 inception, 145 firms have traded on NFX.

For the first quarter of 2017, the combined matched market share consisted of 17.1% at Nasdaq PHLX, 9.5% at The Nasdaq Options Market, 0.7% at Nasdaq BX, 9.5% at Nasdaq ISE, 5.6% at Nasdaq GEMX and 0.1% at Nasdaq MRX. For the fourth quarter of 2016, the combined matched market share consisted of 15.7% at Nasdaq PHLX, 8.6% at The Nasdaq Options Market, 0.7% at Nasdaq BX, 11.2% at Nasdaq ISE, 2.8% at Nasdaq GEMX and 0.2% at Nasdaq MRX.

For the first quarter of 2017, the combined matched market share consisted of 14.0% at The Nasdaq Stock Market, 2.7% at Nasdaq BX and 0.9% at Nasdaq PSX. For the fourth quarter of 2016, the combined matched market share consisted of 13.6% at The Nasdaq Stock Market, 2.6% at Nasdaq BX and 1.0% at Nasdaq PSX

ABOUT NASDAQ

Nasdaq (Nasdaq:NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today’s global capital markets. As the creator of the world’s first electronic stock market, its technology powers more than 89 marketplaces in 50 countries, and 1 in 10 of the world’s securities transactions. Nasdaq is home to 3,800 total listings with a market value of $11.0 trillion. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.

NON-GAAP INFORMATION

In addition to disclosing results determined in accordance with U.S. GAAP, Nasdaq also discloses certain non-GAAP results of operations, including, but not limited to, net income attributable to Nasdaq, diluted earnings per share, operating income, and operating expenses, that include certain adjustments or exclude certain charges and gains that are described in the reconciliation table of U.S. GAAP to non-GAAP information provided at the end of this release. Management uses this non-GAAP information internally, along with U.S. GAAP information, in evaluating our performance and in making financial and operational decisions. We believe our presentation of these measures provides investors with greater transparency and supplemental data relating to our financial condition and results of operations. In addition, we believe the presentation of these measures is useful to investors for period-to-period comparisons of results as the items described below do not reflect ongoing operating performance.

These measures are not in accordance with, or an alternative to, U.S. GAAP, and may be different from non-GAAP measures used by other companies. Investors should not rely on any single financial measure when evaluating our business. We recommend investors review the U.S. GAAP financial measures included in this earnings release. When viewed in conjunction with our U.S. GAAP results and the accompanying reconciliations, we believe these non-GAAP measures provide greater transparency and a more complete understanding of factors affecting our business than U.S. GAAP measures alone.

We understand that analysts and investors regularly rely on non-GAAP financial measures, such as non-GAAP net income attributable to Nasdaq, non-GAAP diluted earnings per share, non-GAAP operating income and non-GAAP operating expenses to assess operating performance. We use these measures because they highlight trends more clearly in our business that may not otherwise be apparent when relying solely on U.S. GAAP financial measures, since these measures eliminate from our results specific financial items, such as those described below, that have less bearing on our ongoing operating performance.

Amortization expense of acquired intangible assets: We amortize intangible assets acquired in connection with various acquisitions. Intangible asset amortization expense can vary from period to period due to episodic acquisitions completed, rather than from our ongoing business operations. As such, if intangible asset amortization is included in performance measures, it is more difficult to assess the day-to-day operating performance of the businesses, the relative operating performance of the businesses between periods and the earnings power of Nasdaq. Management does not consider intangible asset amortization expense for the purpose of evaluating the performance of our business or its managers or when making decisions to allocate resources. Therefore, we believe performance measures excluding intangible asset amortization expense provide investors with a more useful representation of our businesses’ ongoing activity in each period.

Restructuring charges: Restructuring charges are associated with our 2015 restructuring plan to improve performance, cut costs and reduce spending and as of March 31, 2016 are primarily related to (i) severance and other termination benefits, (ii) asset impairment charges, and (iii) other charges. We exclude these restructuring costs because these costs do not reflect future operating expenses and do not contribute to a meaningful evaluation of Nasdaq’s ongoing operating performance or comparison of Nasdaq’s performance between periods.

Merger and strategic initiatives expense: We have pursued various strategic initiatives and completed a number of acquisitions in recent years which have resulted in expenses which would not have otherwise been incurred. These expenses generally include integration costs, as well as legal, due diligence and other third party transaction costs. The frequency and the amount of such expenses vary significantly based on the size, timing and complexity of the transaction. Accordingly, we exclude these costs for purposes of calculating non-GAAP measures which provide a more meaningful analysis of Nasdaq’s ongoing operating performance or comparisons in Nasdaq’s performance between periods.

Asset impairment charges: Intangible assets that have indefinite lives are reviewed for impairment at least annually, or when indicators of impairment are present. For the quarter ended December 31, 2016, we recorded a pre-tax, non-cash asset impairment charge of $578 million related to the eSpeed trade name. The impairment charge was the result of a decline in operating performance and the rebranding of the trade name due to a strategic change in the direction of our Fixed Income business.

Other significant items: We have excluded certain other charges or gains that are the result of other non-comparable events to measure operating performance. For 2016, other significant items primarily included accelerated expense due to the retirement of the company’s former CEO for equity awards previously granted, a regulatory fine received by our exchange in Stockholm and Nasdaq Clearing, a sublease loss reserve on space we currently occupy due to excess capacity, and the impact of the write-off of an equity method investment, partially offset by a gain resulting from the sale of a percentage of a separate equity method investment.

Foreign exchange impact: In countries with currencies other than the U.S. dollar, revenues and expenses are translated using monthly average exchange rates. Certain discussions in this release isolate the impact of year-over-year foreign currency fluctuations to better measure the comparability of operating results between periods. Operating results excluding the impact of foreign currency fluctuations are calculated by translating the current period’s results by the prior period’s exchange rates.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Information set forth in this communication contains forward-looking statements that involve a number of risks and uncertainties. Nasdaq cautions readers that any forward-looking information is not a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking information.  Such forward-looking statements include, but are not limited to (i) projections relating to our future financial results, total shareholder returns, growth, trading volumes, products and services, order backlog, taxes and achievement of synergy targets, (ii) statements about the closing or implementation dates and benefits of certain acquisitions and other strategic, restructuring, technology, de-leveraging and capital return initiatives, (iii) statements about our integrations of our recent acquisitions, (iv) statements relating to any litigation or regulatory or government investigation or action to which we are or could become a party, and (v) other statements that are not historical facts. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq’s control. These factors include, but are not limited to, Nasdaq’s ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk, U.S. and global competition, and other factors detailed in Nasdaq’s filings with the U.S. Securities and Exchange Commission, including its annual reports on Form 10-K and quarterly reports on Form 10-Q which are available on Nasdaq’s investor relations website at http://ir.nasdaq.com and the SEC’s website at www.sec.gov. Nasdaq undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

WEBSITE DISCLOSURE

Nasdaq intends to use its website, ir.nasdaq.com, as a means for disclosing material non-public information and for complying with SEC Regulation FD and other disclosure obligations. These disclosures will be included on Nasdaq’s website under “Investor Relations.”

NDAQF

 Nasdaq, Inc. 
 Condensed Consolidated Statements of Income (Loss) 
 (in millions, except per share amounts) 
(unaudited)
     
  Three Months Ended 
 March 31,   December 31,   March 31, 
 2017  2016  2016
 Revenues:       
 Market Services $   606 $   594 $   572
 Transaction-based expenses:    
 Transaction rebates   (301 )     (286 )     (283 )
 Brokerage, clearance and exchange fees   (87 )     (88 )     (88 )
 Total Market Services revenues less transaction-based expenses   218   220   201
 
 Corporate Services   160   167   143
 Information Services   138   135   133
 Market Technology   67   77   57
           
  Revenues less transaction-based expenses    583     599     534
     
 Operating Expenses: 
 Compensation and benefits   161   180   152
 Professional and contract services   36   43   35
 Computer operations and data communications   30   31   25
 Occupancy   23   24   20
 General, administrative and other   19   22   14
 Marketing and advertising   7   7   6
 Depreciation and amortization   45   45   38
 Regulatory   8   14   7
 Merger and strategic initiatives   6   20   9
 Restructuring charges   9
  Total operating expenses    335     386     315
   
 Operating income    248   213   219
 Interest income   2   1   1
 Interest expense   (37 )   (37 )   (28 )
 Asset impairment charges   (578 )
 Other investment income   1
 Net income (loss) from unconsolidated investees   4   (3 )   2
 Income (loss) before income taxes    217   (404 )   195
 Income tax provision (benefit)   48   (180 )   63
 Net income (loss) attributable to Nasdaq  $   169   $   (224 )   $   132
     
 Per share information: 
 Basic earnings (loss) per share $   1.02 $   (1.35 ) $   0.80
 Diluted earnings (loss) per share $   0.99 $   (1.35 ) $   0.78
 Cash dividends declared per common share $   0.32 $   0.32 $   0.57
 
 Weighted-average common shares outstanding 
  for earnings (loss) per share: 
 Basic   166.5   165.8   164.3
 Diluted (1)   170.2   165.8   168.4
(1) Due to the net loss for the quarter ended December 31, 2016, the diluted earnings (loss) per share calculation excludes 5.7 million of employee stock awards as they were antidilutive.

 

Nasdaq, Inc.
Revenue Detail
(in millions)
(unaudited)
           
   Three Months Ended 
   March 31,   December 31,   March 31, 
 2017  2016  2016
 MARKET SERVICES REVENUES       
Equity Derivative Trading and Clearing Revenues $   191 $   173 $   101
 Transaction-based expenses:
  Transaction rebates   (113 )   (97 )   (48 )
  Brokerage, clearance and exchange fees   (10 )   (8 )   (5 )
  Total net equity derivative trading and clearing revenues   68   68   48
Cash Equity Trading Revenues   320   326   382
 Transaction-based expenses:
  Transaction rebates   (183 )   (185 )   (230 )
  Brokerage, clearance and exchange fees   (76 )   (79 )   (82 )
  Total net cash equity trading revenues   61   62   70
Fixed Income and Commodities Trading and Clearing Revenues    25   25   26
 Transaction-based expenses:
  Transaction rebates   (5 )   (4 )   (5 )
  Brokerage, clearance and exchange fees   (1 )   (1 )   (1 )
  Total net fixed income and commodities trading and clearing revenues   19   20   20
Trade Management Services Revenues   70   70   63
Total Net Market Services revenues   218   220   201
 CORPORATE SERVICES REVENUES
Corporate Solutions revenues   95   98   77
Listings Services revenues   65   69   66
Total Corporate Services revenues   160   167   143
 INFORMATION SERVICES REVENUES
Data Products revenues   108   105   105
Index Licensing and Services revenues   30   30   28
Total Information Services revenues   138   135   133
MARKET TECHNOLOGY REVENUES   67   77   57
 Revenues less transaction-based expenses  $   583 $   599 $   534

 

Nasdaq, Inc.
Condensed Consolidated Balance Sheets 
(in millions)
March 31, December 31,
 2017  2016
Assets (unaudited)
Current assets:
Cash and cash equivalents $   386 $   403
Restricted cash   78   15
Financial investments, at fair value   220   245
Receivables, net   467   429
Default funds and margin deposits   3,633   3,301
Other current assets   163   167
Total current assets   4,947   4,560
Property and equipment, net   376   362
Deferred tax assets   617   717
Goodwill   6,070   6,027
Intangible assets, net   2,082   2,094
Other non-current assets   398   390
Total assets $   14,490 $   14,150
Liabilities 
Current liabilities:
Accounts payable and accrued expenses $   187 $   175
Section 31 fees payable to SEC   81   108
Accrued personnel costs   110   207
Deferred revenue   322   162
Other current liabilities   174   129
Default funds and margin deposits   3,633   3,301
Current portion of debt obligations   379
Total current liabilities   4,886   4,082
Debt obligations 3,242 3,603
Deferred tax liabilities 702 720
Non-current deferred revenue 164 171
Other non-current liabilities 144 144
Total liabilities   9,138   8,720
Commitments and contingencies 
Equity
Nasdaq stockholders’ equity:
Common stock   2   2
Additional paid-in capital   2,963   3,104
Common stock in treasury, at cost   (221 )   (176 )
Accumulated other comprehensive loss   (987 )   (979 )
Retained earnings   3,595   3,479
Total Nasdaq stockholders’ equity   5,352   5,430
Total liabilities and equity $   14,490 $   14,150

 

Nasdaq, Inc.
Reconciliation of U.S. GAAP Net Income (Loss), Diluted Earnings (Loss) Per Share, Operating Income and 
Operating Expenses to Non-GAAP Net Income, Diluted Earnings Per Share, Operating Income, and Operating Expenses
(in millions, except per share amounts)
(unaudited)
 Three Months Ended 
 March 31,   December 31,   March 31, 
2017 2016 2016
   
U.S. GAAP net income (loss) attributable to Nasdaq $   169 $   (224 ) $   132
Non-GAAP adjustments:
Amortization expense of acquired intangible assets (1)   23   23   17
Merger and strategic initiatives (2)   6   20   9
Restructuring charges (3)   9
Asset impairment charges (4)   578
Regulatory matter (5)   6
Executive compensation (6)   12
Sublease loss reserve (7)   1
Other (8)   6
Total non-GAAP adjustments   29   646   35
Non-GAAP adjustment to the income tax provision (9)   (11 )   (261 )   (14 )
Total non-GAAP adjustments, net of tax   18   385   21
Non-GAAP net income attributable to Nasdaq $   187 $   161 $   153
U.S. GAAP diluted earnings (loss) per share $   0.99 $   (1.35 ) $   0.78
Adjustment to GAAP loss per share to include fully diluted weighted average shares   0.03
Total adjustments from non-GAAP net income above   0.11   2.27   0.13
Non-GAAP diluted earnings per share $   1.10 $   0.95 $   0.91
 Weighted-average diluted common shares outstanding 
  for earnings (loss) per share:  170.2 169.3 168.4
(1) Refer to the non-GAAP information section of the earnings release for further discussion of why we consider amortization expense of acquired intangible assets to be a non-GAAP adjustment.

(2) For the three months ended March 31, 2017 and December 31, 2016, merger and strategic initiatives expense primarily related to our acquisitions of International Securities Exchange, or ISE, and Boardvantage, Inc and other strategic initiatives.  For the three months ended March 31, 2016, merger and strategic initiatives expense primarily related to our acquisitions of Nasdaq CXC and Marketwired L.P. Refer to the non-GAAP information section of the earnings release for further discussion on why we consider merger and strategic initiatives expense to be a non-GAAP adjustment.

(3) Restructuring charges for the three months ended March 31, 2016 are associated with our 2015 restructuring plan to improve performance, cut costs, and reduce spending and are primarily related to severance and other termination benefits, asset impairment charges and other charges. In June 2016, we completed our 2015 restructuring plan. Refer to the non-GAAP information section of the earnings release for further discussion of why we consider restructuring charges to be a non-GAAP adjustment.

(4) For the three months ended December 31, 2016, we recorded a pre-tax, non-cash intangible asset impairment charge of $578 million related to the full write-off of the eSpeed trade name.  The impairment charge was the result of a decline in operating performance and the rebranding of our Fixed Income business. Refer to the non-GAAP information section of the earnings release for further discussion of why we consider asset impairment charges to be a non-GAAP adjustment.

(5) In December 2016, we were issued a $6 million fine by the Swedish Financial Supervisory Authority, or SFSA, as a result of findings in connection with its investigations of cybersecurity processes at our Nordic exchanges and clearinghouse. The SFSA’s conclusions related to governance issues rather than systems and platform security. We have appealed the SFSA’s decision, including the amount of the fine.  This charge is included in regulatory expense in the Condensed Consolidated Statements of Income (Loss) for the three months ended December 31, 2016.

(6) For the three months ended December 31, 2016, we recorded $12 million in accelerated expense due to the retirement of the company’s former CEO for equity awards previously granted.

(7) For the three months ended December 31, 2016, we established a sublease loss reserve on space we currently occupy due to excess capacity.

(8) Other charges primarily include the impact of the write-off of an equity method investment, partially offset by a gain resulting from the sale of a percentage of a separate equity method investment. We recorded the net loss in net income (loss) from unconsolidated investees in the Condensed Consolidated Statements of Income (Loss) for the three months ended December 31, 2016.

(9) The non-GAAP adjustment to the income tax provision primarily includes the tax impact of each non-GAAP adjustment.

 

Nasdaq, Inc.
Reconciliation of U.S. GAAP Net Income (Loss), Diluted Earnings (Loss) Per Share, Operating Income and 
Operating Expenses to Non-GAAP Net Income, Diluted Earnings Per Share, Operating Income, and Operating Expenses
(in millions)
(unaudited)
 Three Months Ended 
 March 31,   December 31,   March 31, 
 2017  2016  2016
U.S. GAAP operating income $   248 $   213 $   219
Non-GAAP adjustments:
Amortization expense of acquired intangible assets (1)   23   23   17
Merger and strategic initiatives (2)   6   20   9
Restructuring charges (3)   9
Regulatory matter (4)   6
Executive compensation (5)   12
Sublease loss reserve (6)   1
Total non-GAAP adjustments   29   62   35
Non-GAAP operating income $   277 $   275 $   254
Revenues less transaction-based expenses  $   583 $   599 $   534
U.S. GAAP operating margin (7) 43 % 36 % 41 %
Non-GAAP operating margin (8) 48 % 46 % 48 %
(1) Refer to the non-GAAP information section of the earnings release for further discussion of why we consider amortization expense of acquired intangible assets to be a non-GAAP adjustment.
(2) For the three months ended March 31, 2017 and December 31, 2016, merger and strategic initiatives expense primarily related to our acquisitions of ISE and Boardvantage, Inc and other strategic initiatives.  For the three months ended March 31, 2016, merger and strategic initiatives expense primarily related to our acquisitions of Nasdaq CXC and Marketwired L.P. Refer to the non-GAAP information section of the earnings release for further discussion on why we consider merger and strategic initiatives expense to be a non-GAAP adjustment.
(3) Restructuring charges for the three months ended March 31, 2016 are associated with our 2015 restructuring plan to improve performance, cut costs, and reduce spending and are primarily related to severance and other termination benefits, asset impairment charges and other charges. In June 2016, we completed our 2015 restructuring plan. Refer to the non-GAAP information section of the earnings release for further discussion of why we consider restructuring charges to be a non-GAAP adjustment.
(4) In December 2016, we were issued a $6 million fine by the SFSA as a result of findings in connection with its investigations of cybersecurity processes at our Nordic exchanges and clearinghouse. The SFSA’s conclusions related to governance issues rather than systems and platform security. We have appealed the SFSA’s decision, including the amount of the fine.  This charge is included in regulatory expense in the Condensed Consolidated Statements of Income (Loss) for the three months ended December 31, 2016.
(5) For the three months ended December 31, 2016, we recorded $12 million in accelerated expense due to the retirement of the company’s former CEO for equity awards previously granted.
(6) For the three months ended December 31, 2016, we established a sublease loss reserve on space we currently occupy due to excess capacity.
(7) U.S. GAAP operating margin equals U.S. GAAP operating income divided by total revenues less transaction-based expenses.
(8) Non-GAAP operating margin equals non-GAAP operating income divided by total revenues less transaction-based expenses.

 

Nasdaq, Inc.
Reconciliation of U.S. GAAP Net Income (Loss), Diluted Earnings (Loss) Per Share, Operating Income and 
Operating Expenses to Non-GAAP Net Income, Diluted Earnings Per Share, Operating Income, and Operating Expenses
(in millions)
(unaudited)
 Three Months Ended 
 March 31,   December 31,   March 31, 
 2017  2016  2016
U.S. GAAP operating expenses $   335 $   386 $   315
Non-GAAP adjustments:
Amortization expense of acquired intangible assets (1)   (23 )   (23 )   (17 )
Merger and strategic initiatives (2)   (6 )   (20 )   (9 )
Restructuring charges (3)   (9 )
Regulatory matters (4)   (6 )
Executive compensation (5)   (12 )
Sublease loss reserve (6)   (1 )
Total non-GAAP adjustments   (29 )   (62 )   (35 )
Non-GAAP operating expenses $   306 $   324 $   280
(1) Refer to the non-GAAP information section of the earnings release for further discussion of why we consider amortization expense of acquired intangible assets to be a non-GAAP adjustment.

(2) For the three months ended March 31, 2017 and December 31, 2016, merger and strategic initiatives expense primarily related to our acquisitions of ISE and Boardvantage, Inc and other strategic initiatives.  For the three months ended March 31, 2016, merger and strategic initiatives expense primarily related to our acquisitions of Nasdaq CXC and Marketwired L.P. Refer to the non-GAAP information section of the earnings release for further discussion on why we consider merger and strategic initiatives expense to be a non-GAAP adjustment.

(3) Restructuring charges for the three months ended March 31, 2016 are associated with our 2015 restructuring plan to improve performance, cut costs, and reduce spending and are primarily related to severance and other termination benefits, asset impairment charges and other charges. In June 2016, we completed our 2015 restructuring plan. Refer to the non-GAAP information section of the earnings release for further discussion of why we consider restructuring charges to be a non-GAAP adjustment.

(4) In December 2016, we were issued a $6 million fine by the SFSA as a result of findings in connection with its investigations of cybersecurity processes at our Nordic exchanges and clearinghouse. The SFSA’s conclusions related to governance issues rather than systems and platform security. We have appealed the SFSA’s decision, including the amount of the fine.  This charge is included in regulatory expense in the Condensed Consolidated Statements of Income (Loss) for the three months ended December 31, 2016.

(5) For the three months ended December 31, 2016, we recorded $12 million in accelerated expense due to the retirement of the company’s former CEO for equity awards previously granted.

(6) For the three months ended December 31, 2016, we established a sublease loss reserve on space we currently occupy due to excess capacity.

 

Nasdaq, Inc.
Total Variance Impact Analysis
(in millions)
(unaudited)
 Three Months Ended   Total
Variance 
Organic
Impact
Acquisition
Impact (1)
FX Impact
@ Prior Year Rates (2)
 March 31,   March 31, 
 2017  2016 $ % $ % $ % $ %
Corporate Services $   160 $   143 $   17 12 % $   2 1 % $   16 11 % $   (1 ) (1 %)
Information Services   138   133   5 4 %   3 2 %   2 2 %
Market Technology   67   57   10 18 %   10 18 %   1 2 %   (1 ) (2 %)
Total non-trading segment revenues $   365 $   333 $   32 10 % $   15 5 % $   19 6 % $   (2 ) (1 %)
(1) Acquisition impact reflects the inclusion of revenues from the 2016 acquisitions of Nasdaq CXC, Marketwired L.P., Boardvantage, Inc. and ISE.

(2) In countries with currencies other than the U.S. dollar, revenues and expenses are translated using monthly average exchange rates. Certain discussions in this release isolate the impact of year-over-year foreign currency fluctuations to better measure the comparability of operating results between periods. Operating results excluding the impact of foreign currency fluctuations are calculated by translating the current period’s results by the prior period’s exchange rates.

Nasdaq, Inc.
Quarterly Key Drivers Detail
(unaudited)
Three Months Ended
 March 31,   December 31,   March 31, 
 2017  2016  2016
Market Services
Equity Derivative Trading and Clearing
U.S. Equity Options
Total industry average daily volume (in millions) 14.6 14.4 15.3
Nasdaq PHLX Options Market matched market share 17.1 % 15.7 % 16.1 %
The Nasdaq Options Market matched market share 9.5 % 8.6 % 7.1 %
Nasdaq BX Options Market matched market share 0.7 % 0.7 % 0.9 %
Nasdaq ISE Options Market matched market share (1) 9.5 % 11.2 %
Nasdaq GEMX Options Market matched market share (1) 5.6 % 2.8 %
Nasdaq MRX Options Market matched market share (1) 0.1 % 0.2 %
Total matched market share executed on Nasdaq’s exchanges 42.5 % 39.2 % 24.1 %
Nasdaq Nordic and Nasdaq Baltic options and futures
Total average daily volume options and futures contracts(2) 338,463 332,410 452,178
Cash Equity Trading
Total U.S.-listed securities
Total industry average daily share volume (in billions)   6.84   7.06   8.56
Matched share volume (in billions)   74.7   76.4   93.7
The Nasdaq Stock Market matched market share 14.0 % 13.6 % 14.9 %
Nasdaq BX matched market share 2.7 % 2.6 % 2.0 %
Nasdaq PSX matched market share 0.9 % 1.0 % 1.0 %
Total matched market share executed on Nasdaq’s exchanges 17.6 % 17.2 % 17.9 %
Market share reported to the FINRA/Nasdaq Trade Reporting Facility 34.9 % 34.2 % 31.9 %
Total market share(3) 52.5 % 51.4 % 49.8 %
Nasdaq Nordic and Nasdaq Baltic securities
Average daily number of equity trades 507,647 492,836 525,857
Total average daily value of shares traded (in billions) $   4.8 $   4.8 $   5.7
Total market share executed on Nasdaq’s exchanges 66.8 % 65.1 % 62.5 %
Fixed Income and Commodities Trading and Clearing
Total U.S. Fixed Income
U.S. fixed income notional trading volume (in billions) $   5,041 $   5,465 $   5,968
Nasdaq Nordic and Nasdaq Baltic fixed income
Total average daily volume fixed income contracts   112,004   92,133   101,470
Commodities
Power contracts cleared (TWh)(4) 379 461 420
Corporate Services
Initial public offerings
Nasdaq 17 25 10
Exchanges that comprise Nasdaq Nordic and Nasdaq Baltic 11 24 8
New listings
Nasdaq(5) 42 83 47
Exchanges that comprise Nasdaq Nordic and Nasdaq Baltic(6) 16 31 14
Number of listed companies
Nasdaq(7)   2,890   2,897   2,852
Exchanges that comprise Nasdaq Nordic and Nasdaq Baltic(8)   910   900   847
 Information Services
Number of licensed ETPs 306 298 226
ETP assets under management (AUM) tracking Nasdaq indexes (in billions) $   138 $   124 $   105
 Market Technology
Order intake (in millions)(9) $   47 $   136 $   22
Total order value (in millions)(10) $   777 $   777 $   783
(1) Matched market share for Nasdaq ISE, Nasdaq GEMX and Nasdaq MRX is not disclosed for the three months ended March 31, 2016 since Nasdaq’s acquisition of ISE closed on June 30, 2016.
(2) Includes Finnish option contracts traded on EUREX Group.
(3) Includes transactions executed on Nasdaq’s, Nasdaq BX’s and Nasdaq PSX’s systems plus trades reported through the Financial Industry Regulatory Authority/Nasdaq Trade Reporting Facility.
(4) Transactions executed on Nasdaq Commodities or OTC and reported for clearing to Nasdaq Commodities measured by Terawatt hours (TWh).
(5) New listings include IPOs, including those completed on a best efforts basis, issuers that switched from other listing venues, closed-end funds and separately listed exchange traded products, or ETPs.
(6) New listings include IPOs and represent companies listed on the Nasdaq Nordic and Nasdaq Baltic exchanges and companies on the alternative markets of Nasdaq First North.
(7) Number of total listings on Nasdaq at period end, including 332 separately listed ETPs at March 31, 2017, 327 at December 31, 2016 and 241 at March 31, 2016.
(8) Represents companies listed on the Nasdaq Nordic and Nasdaq Baltic exchanges and companies on the alternative markets of Nasdaq First North at period end.
(9) Total contract value of orders signed during the period.
(10) Represents total contract value of orders signed that are yet to be recognized as revenue.
MEDIA RELATIONS CONTACT:
Allan Schoenberg
+1.212.231.5534
[email protected]

INVESTOR RELATIONS CONTACT:
Ed Ditmire, CFA
+1.212.401.8737
[email protected]

Nasdaq Announces 19% Increase in Quarterly Dividend to $0.38 Per Share

NEW YORK, April 26, 2017 (GLOBE NEWSWIRE) — The Board of Directors of Nasdaq, Inc (Nasdaq:NDAQ) has declared a regular quarterly dividend of $0.38 per share on the company’s outstanding common stock, an increase of 19% from the prior $0.32 per share quarterly dividend.

The dividend is payable on June 30, 2017 to shareowners of record at the close of business on June 16, 2017.  The Board of Directors has adopted a dividend policy with the intention to provide shareholders with regular and growing dividends over the long term as earnings and cash flow grow.

Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to approval by the Board of Directors.

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

Information set forth in this communication contains forward-looking statements that involve a number of risks and uncertainties.  Nasdaq cautions readers that any forward-looking information is not a guarantee of future performance and that actual results could differ materially from those contained in the forward-looking information.  Such forward-looking statements include, but are not limited to (i) projections relating to our future financial results, total shareholder returns, growth, trading volumes, products and services, order backlog, taxes and achievement of synergy targets, (ii) statements about the closing or implementation dates and benefits of certain acquisitions and other strategic, restructuring, technology, de-leveraging and capital return initiatives, (iii) statements about our integrations of our recent acquisitions, (iv) statements relating to any litigation or regulatory or government investigation or action to which we are or could become a party, and (v) other statements that are not historical facts.  Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq’s control.  These factors include, but are not limited to, Nasdaq’s ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk, U.S. and global competition, and other factors detailed in Nasdaq’s filings with the U.S. Securities and Exchange Commission, including its annual reports on Form 10-K and quarterly reports on Form 10-Q which are available on Nasdaq’s investor relations website at http://ir.nasdaq.com and the SEC’s website at www.sec.gov.  Nasdaq undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

ABOUT NASDAQ

Nasdaq (Nasdaq:NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today’s global capital markets. As the creator of the world’s first electronic stock market, its technology powers more than 89 marketplaces in 50 countries, and 1 in 10 of the world’s securities transactions. Nasdaq is home to 3,800 total listings with a market value of $11.0 trillion. To learn more, visit: nasdaq.com/ambition or business.nasdaq.com.

NDAQF

MEDIA RELATIONS CONTACT:
Allan Schoenberg
+1.212.231.5534
[email protected]

INVESTOR RELATIONS CONTACT:
Ed Ditmire, CFA 
+1.212.401.8737
[email protected]